Clinical Opal - Androgen abuse recovery in a younger male
Jeremy is a 22-year-old who presents with low energy, fatigue, weaker erections and decreasing libido. He plays football and works out at the gym a few times a week.
Jeremy’s physical examination shows a moderate reduction in testes size of approximately 10ml. Jeremy’s blood tests return with total testosterone extremely low at 1.2nmol/L, and LH 1IU/L, indicating secondary hypogonadism along with a high creatinine (124umol/L) and haematocrit (55%) and upper normal haemoglobin (178g/L).
What do these results suggest?
In this case Jeremy’s symptoms and clinical findings are consistent with withdrawal from androgenic steroids used for muscle and performance enhancement. Other diagnoses have been excluded. This presents as transient hypogonadotropic hypogonadism. His pituitary function will recover over time.
Jeremy’s recovery may take many months depending mainly on the time since cessation. The outlook for recovery of fertility and testosterone production is generally good but prolonged. The support of an interdisciplinary team including the general practitioner, endocrinologist and psychologist can help to support Jeremy.
Learn more in our Androgen use, misuse and abuse online learning modules.
References:
Handelsman DJ. Androgen Physiology, Pharmacology, Use and Misuse. In: Feingold et al., editors. Endotext available from: https://www.ncbi.nlm.nih.gov/books/NBK279000/
Anawalt, 2019. Diagnosis and Management of Anabolic Androgenic Steroid Use. The Journal of Clinical Endocrinology & Metabolism
Christou & Tigas, 2018. Recovery of reproductive function following androgen abuse. Current Opinion in Endocrinology, Diabetes and Obesity
Become a member and get unlimited access to 100s of hours of premium education.
Learn moreMervyn, is day 2 following surgical repair for a fractured neck of femur. He has mild dementia, lives at home with family support and is normally chatty, interactive and knows his family when they visit.
Marjory is a 68 year old in-patient who is 2 days post hip replacement. She is on rivaroxaban (xarelto) for VTE prophylaxis. You find her sitting on the floor of the bathroom, alert but in pain.
We explore the case of Edward, a patient with acute kidney injury (AKI), focusing on renal protection strategies. It explores fluid management, blood pressure control, nephrotoxic drug adjustments, and electrolyte monitoring. Treatment considerations include vasoactive medications, dialysis options like CRRT, and medication dosing to support renal recovery and prevent complications.